DLQIX
Price
$15.07
Change
-$0.08 (-0.53%)
Updated
Jun 22 closing price
Net Assets
138.65M
VTSAX
Price
$179.51
Change
-$0.62 (-0.34%)
Updated
Jun 22 closing price
Net Assets
2.31T
Interact to see
Advertisement

DLQIX vs VTSAX

DLQIX vs VTSAX Comparison Chart in %
View a ticker or compare two or three
VS
DLQIX vs. VTSAX commentary
Jun 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DLQIX is a Buy and VTSAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VTSAX has more cash in the bank: 2.31T vs. DLQIX (139M). VTSAX pays higher dividends than DLQIX: VTSAX (1.00) vs DLQIX (0.52). DLQIX was incepted earlier than VTSAX: DLQIX (29 years) vs VTSAX (26 years). DLQIX (0.88) is less costly to investors than VTSAX (0.04). DLQIX is a more actively managed with annual turnover of: 38.87 vs. VTSAX (3.00). DLQIX has a lower initial minimum investment than VTSAX: DLQIX (1000) vs VTSAX (3000). VTSAX annual gain was more profitable for investors over the last year : 26.18 vs. DLQIX (0.75). VTSAX return over 5 years is better than : 68.77 vs. DLQIX (-47.03).
DLQIXVTSAXDLQIX / VTSAX
Total Expense Ratio0.750.041,875%
Annual Report Gross Expense Ratio0.880.042,200%
Fund Existence29 years26 years-
Gain YTD3.62510.39635%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets139M2.31T0%
Annual Yield % from dividends0.521.0052%
Returns for 1 year0.7526.183%
Returns for 3 years-22.9472.62-32%
Returns for 5 years-47.0368.77-68%
Returns for 10 years-3.01269.62-1%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NMIMX30.520.03
+0.09%
Columbia Large Cap Enhanced Core Inst
CIRCX82.040.04
+0.05%
American Funds Capital Income Bldr 529C
PHLCX9.59N/A
N/A
PGIM Jennison Health Sciences C
STLYX43.71N/A
N/A
SEI Tax-Managed Large Cap Y (SIMT)
TMITX9.64N/A
N/A
Transamerica Mid Cap Growth I3